An initial blueprint for myogenic differentiation

AUTOR(ES)

Blais, Alexandre

FONTE

Cold Spring Harbor Laboratory Press

RESUMO

We have combined genome-wide transcription factor binding and expression profiling to assemble a regulatory network controlling the myogenic differentiation program in mammalian cells. We identified a cadre of overlapping and distinct targets of the key myogenic regulatory factors (MRFs)—MyoD and myogenin—and Myocyte Enhancer Factor 2 (MEF2). We discovered that MRFs and MEF2 regulate a remarkably extensive array of transcription factor genes that propagate and amplify the signals initiated by MRFs. We found that MRFs play an unexpectedly wide-ranging role in directing the assembly and usage of the neuromuscular junction. Interestingly, these factors also prepare myoblasts to respond to diverse types of stress. Computational analyses identified novel combinations of factors that, depending on the differentiation state, might collaborate with MRFs. Our studies suggest unanticipated biological insights into muscle development and highlight new directions for further studies of genes involved in muscle repair and responses to stress and damage.

Documentos Relacionados

• An essential role of phosphatidylinositol 3-kinase in myogenic differentiation
• Type beta transforming growth factor is an inhibitor of myogenic differentiation.
• BOC, an Ig superfamily member, associates with CDO to positively regulate myogenic differentiation
• Blueprint for Medical Care
• RIP2, a Checkpoint in Myogenic Differentiation